Stay updated on HERV-W Antagonist GNbAC1 Clinical Trial
Sign up to get notified when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.

Latest updates to the HERV-W Antagonist GNbAC1 Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 is displayed on the page, replacing the previous v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and the prior funding/operating-status notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedThe site now displays a government funding status notice and the page revision label updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check48 days agoChange DetectedShow glossary feature added and a new 'Last Update Submitted that Met QC Criteria' field is now included under Study Record Dates, with the footer updated to 'Revision: v3.4.0'. The existing 'Last Update Submitted that met QC Criteria' (lowercase m), 'No FEAR Act data' (lowercase d), and 'Revision: v3.3.4' entries were removed.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision v3.3.4 was added and Revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision updated to v3.3.3 and removal of the HHS Vulnerability Disclosure link along with the previous Revision: v3.3.2 indicate a minor site maintenance update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to HERV-W Antagonist GNbAC1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.